Effects of pirfenidone on transforming growth factor-β gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 367-373

  Iyer, S N ^a   Gurujeyalakshmi, G ^a   Giri, S N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; PIRFENIDONE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATORY CELL; INTRATRACHEAL DRUG ADMINISTRATION; LUNG FIBROSIS; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CRICETINAE; DOWN-REGULATION; LUNG; MACROPHAGES; MALE; MESOCRICETUS; PULMONARY FIBROSIS; PYRIDONES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032842405     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bitterman PB, Aldelberg S and Crystal RG (1983) Mechanisms of pulmonary fibrosis: Spontaneous release of alveolar macrophage-derived growth factors in the interstitial lung disorders. J Clin Invest 72:1801-1813.
2. Border WA and Noble NA (1994) Transforming growth factor β in the tissue fibrosis. New Engl J Med 331:1286-1292.
3. Breen E, Shull S, Burne S, Absher M, Kelly J, Phan S and Cutroneo KR (1992) Bleomycin regulation of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. Am J Respir Cell Mol Biol 6:146-152.
4. Broekelmann TJ, Limper AH, Colby TV and McDonald JA (1991) Transforming growth factor β is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88:6642-6646.
5. Carrington CB, Gaensler EA, Coutur RE, Fitzgerald M and Gupta RG (1978) Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298:801-809.
6. Chandler DB, Hyde DM and Giri SN (1983) Morphometric estimations of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol 112:170-177.
7. Crouch E (1990) Pathophysiology of pulmonary fibrosis. Am J Physiol 259:159-184.
8. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty JP, Angel P and Heath JK (1987) TGF-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904.
9. Gauldie J, Jordana M and Cox G (1993) Cytokines and pulmonary fibrosis. Thorax 48:931-935.
10. Giri SN (1990) Pharmacological perspective in pulmonary fibrosis research, in Focus on Pulmonary and Toxicology (Hollinger MA ed) vol 2, pp 19-55, CRC, Boca Raton, Florida.
11. Giri SN, Hollinger MA and Schiedt MJ (1981) The effects of paraquat and superoxide dismutase on pulmonary vascular permeability and edema in mice. Arch Environ Health 36:149-154.
12. Giri SN, Hyde DM, Braun R, Gaarde W, Harper JR and Pierschbacher MD (1997) Anti-fibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 97:1205-12116.
13. Giri SN, Hyde DM and Hollinger MA (1993) Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48:959-966.
14. Gurujeyalakshmi G, Hollinger MA and Giri SN (1998) Regulation of TGF-β mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. Am J Respir Cell Mol Biol 18:334-342.
15. Gurujeyalakshmi G, Hollinger MA and Giri SN (1999) Pirfenidone inhibits PDGF isoforms in the bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol 276 (Lung Cell Mol Physiol 20):L311-L318.
16. Gurujeyalakshmi G, Hollinger MA and Giri SN (1999) Pirfenidone inhibits PDGF isoforms in the bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol 276 (Lung Cell Mol Physiol 20):L311-L318.
17. Gurujeyalakshmi G, Iyer SN, Hollinger MA and Giri SN (1996) Procollagen gene expression is downregulated by taurine and niacin at the transcriptional level in the bleomycin hamster model of lung fibrosis. J Pharm Exp Ther 277:1152-1157.
18. Iyer SN, Gurujeyalakshmi G and Giri SN (1999) Downregulation of procollagen genes at the transcriptional level in the bleomycin-induced model of lung fibrosis. J Pharm Exp Ther 289:211-218.
19. Iyer SN, Margolin SB, Hyde DM and Giri SN (1998) Lung fibrosia is ameliorated by pirfenidone fed in diet after the second dose in a three dose bleomycin hamster model. Exp Lung Res 24:119-132.
20. Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB and Giri SN (1995) Dietary intake of pirfenidone ameliorates bleomycin induced lung fibrosis in hamsters. J Lab Clin Med 126:779-785.
21. Jordana M, Richards C, Irving LB and Gauldie J (1988) Spontaneous in vitro release of alveolar-macrophage cytokines after the intratracheal instillation of bleomycin in rats. Characterization and kinetic studies. Am Rev Respir Dis 137:1135-1140.
22. Kaneko M, Inoue H, Nakazawa R, Azuma N, Suzuki M, Yamauchi S and Margolin SB (1998) Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin. Exp Immunol 113:72-76.
23. Khalil N, Berenzay OH, Sporn MB and Greenberg AH (1989) Macrophage production of TGF-β and fibroblast synthesis in chronic pulmonary inflammation. J Exp Med 170:727-737.
24. Khalil N, Corne S, Whitman C and Yacyshyn H (1996) Plasmin regulates the activation of latent TGF-β secreted by alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 15:252-259.
25. Khalil N, O'Connor RN, Unruh MW, Warren PW, Flanders KC, Kemp A, Berenzay OH and Greenberg AH (1991) Increased production and immunohistochemkal localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Resp Cell Mol Biol 5:155-162.
26. Khalil N, Whitman C, Li Z, Danielpour D and Greenberg A (1993) Regulation of alveolar-macrophage TGF-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 92:1812-1818.
27. Martinet Y, William NR, Grotendorst GR, Martin GR and Crystal RG (1987) Exaggerated spontaneous release of platelet derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Eng J Med 317:202-209.
28. Pierce GP, Mustoe TA, Lingelback J, Masakowski OR, Gramates P and Duel TF (1989) Transforming growth factor reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages platelet derived growth factor. Proc Natl Acad Sci USA 86:2233-2269.
29. Piguet PF, Collart MA, Grau GE, Kapanci Y and Vasalli P (1989) Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170:655-663.
30. Postlethwaite AE, Keski-Oja J, Moses HL and Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 185:251-256.
31. Raghow R, Lurie S, Seyer JM and Kang AH (1985) Profiles of steady state levels of mRNAs coding for type I procollagen, elastin and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest 76: 1733-1739.
32. Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL and Kang AH (1987) TGF-β increases steady state levels of type I procollagen and fibronectin mRNAs post transcriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1258-1288.
33. Roberts AB and Sporn MB (1990) The transforming growth factor β's, in Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology (Sporn MB and Roberts AB eds) vol 95/1, pp 419-472, Springer-Verlag, Heidelberg, Germany.
34. Shaw RJ and Kelly J (1995) Macrophages/Monocytes in Pulmonary Fibrosis (Phan SM and Thrall RS eds) vol 80, ch 12, pp 135-171, Marcel Dekker, Inc., New York.
35. Sporn MB, Roberts AB, Wakefield LM and Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor β. J Cell Biol 105:1039-1045.
36. Sugigura Y and Kikuchi T (1978) Formation of superoxide and hydroxy radicals in iron (II)- bleomycin- oxygen system: Electron spin resonance detection by spin trapping. J Antibiot (Tokyo) 31:1310-1312.
37. Valleyathan V, Giri SN, Leonard SL and Margolin SB (1996) Free radical scavenging efficiency of pirfenidone. A novel antifibrotic drug. Am J Resp Crit Care Med 153:738A.
38. Von Andrian UH, Chambers JD, Mcevoy LM, Bargatz RF, Arferosk E and Buther EC (1991) Two-step model of leukocyte endothelial cell interaction in inflammation: Distinct role for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 88:7538-7542.
39. Westergren-Thorsson G, Hernass J, Sarnstrand B, Olderberg A, Heinegard D and Malmstrom A (1993) Altered expression of small proteoglycans, collagen and transforming growth factor β in developing bleomycin-induced fibrosis in rats. J Clin Invest 92:632-637.
40. Whal SM (1994) Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 180:1587-1590.
41. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM and Roberts AB (1987) Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84:5782-5788.
42. Wilcox ML, Kervitsky A, Watters LC and King TE (1988) Quantification of cells recovered from bronchoalveolar lavage: Comparison of cytocentrifuge preparations with filter method. Am Rev Respir Dis 158:74-80.
43. Yamakage A, Kikuchi K, Smith EA, Carwile LeRoy E and Trojanowska M (1992) Selective up-regulation of platelet-derived growth factor a receptors by TGF-β in scleroderma fibroblasts. J Exp Med 175:1227-1234.